“Role for drug delivery formulations to capture the benefits of chemical synthetic lethal interactions,” by Dr. Marcel Bally, Head and Distinguished Scientist, Department of Experimental Therapeutics of BC Cancer Agency.
Monday, September 28, 2015 @ 3:00 pm, LSC #3, 2350 Health Sciences Mall.